RE: Nipt27 Nov 2024 11:09
The hospital of the Medical Center of the Administration of the President of the Republic of Kazakhstan is the first in the country to use an innovative test that detects chromosomal abnormalities in the uterus at an early stage.
The new method allows to detect Down syndrome from the 10th week of pregnancy with 99% accuracy. The study requires only a sample of the mother's blood, so this procedure does not require a completely safe and invasive intervention.
The test was developed by British company Yourgete Health, which is based on the technology for analyzing the extracellular DNA of the mother's blood. This method can detect not only Down syndrome (trisomy 21), but also other chromosomal abnormalities, such as 18 (Edwards syndrome) and 13 (Patau syndrome) trisomia, as well as disorders associated with sexual chromosomes. The feature of the test is that it reduces the risk of false positive or negative outcomes because of the high sensitivity.
The new approach significantly reduces the need for invasive diagnostic methods, such as amniocentesis and chorion biopsy, which pose a threat to the health of mother and fetus.
At the international conference in the Hospital of the Ministry of Internal Affairs of Kazakhstan, experts from Kazakhstan and abroad discussed the prospects for the use of non-invasive prenatal testing. The event was attended by more than 230 doctors and experts, including representatives of the Ministry of Health of Kazakhstan, the British Embassy, as well as test developers of Yourget Health.
Indian expert Brinderjit Singh Battar, head of the department of reproductive and clinical genomics at a diagnostic center Agilus Diagnostics, and Thiago Justu, a representative of British company Yourgene Health, gave examples of what the test did in international practice.
Gulshara Abildinova, the head of the Laboratory of Personalized Genomic Diagnostics of the Hospital of the Ministry of Internal Affairs of the Republic of Kazakhstan, noted the importance of introduction of IAPT in Kazakhstan, noting that this method will be an important tool for reducing infant mortality and simplifying the lives of people preparing to become parents.
"This test will allow us to get timely information about the health of the child coming to life. The accurate diagnosis at the early stage gives parents and doctors time to prepare and make decisions, which is especially important in difficult situations, - said Gulshara Abildinova."
Sign In
Follow the stocks
